Sleep apnea is common in patients with coronary artery disease

Christian Prinz1, Thomas Bitter, Cornelia Piper

  • 1Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany, akleemeyer@hdz-nrw.de.

Insights

Sleep-disordered breathing (SDB) is common in coronary artery disease (CAD) patients and linked to higher inflammation markers. This suggests SDB may worsen CAD progression or trigger acute cardiac events.

Area of Science:

  • Cardiology
  • Sleep Medicine
  • Inflammation Research

Background:

  • Sleep-disordered breathing (SDB) is a known factor impacting cardiac disease prognosis.
  • Coronary artery disease (CAD) patients often have undiagnosed sleep issues.
  • Chronic inflammation plays a role in the development and progression of CAD.

Purpose of the Study:

  • To investigate the prevalence of SDB in patients with established CAD and preserved left ventricular function.
  • To explore the association between SDB, systemic inflammation markers (hs-CRP, fibrinogen), and CAD.
  • To determine if SDB severity correlates with inflammatory markers in this patient group.

Main Methods:

  • Cardiorespiratory polygraphy was used to diagnose SDB in 257 CAD patients.
  • High-sensitivity C-reactive protein (hs-CRP) and fibrinogen levels were measured in 251 patients.
  • Patients were categorized based on SDB presence, type (central/obstructive), and hs-CRP levels.

Main Results:

  • SDB was prevalent in 188 (73%) of the CAD patients studied.
  • Patients with SDB exhibited significantly higher fibrinogen levels compared to those without SDB (p=0.01).
  • Higher hs-CRP levels (>0.5 mg/dl) were associated with significantly more severe SDB (p=0.01).

Conclusions:

  • SDB is highly prevalent in patients with coronary artery disease.
  • SDB in CAD patients is associated with elevated markers of chronic inflammation.
  • These findings suggest a potential link between SDB, inflammation, and CAD progression or acute coronary events.

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...